Denmark’s Lundbeck is set to acquire Longboard Pharmaceuticals for about $2.5 billion. California-based Longboard has a small molecule, bexicaserin, in late-stage clinical trials for certain ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

The No. 1 Nanooks were in Colorado over the weekend to take on two other top-ranked rifle programs on Saturday and Sunday. They defeated No. 7 Air Force in their first meeting before falling to No ...

(Bloomberg) -- H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug ...

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.

Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...

The University of Alaska Fairbanks’ nearly month-long winning streak on the volleyball court came to an end on Saturday, as the Nanooks lost the last three sets of a five-set match at Central ...

Oct 14 (Reuters) - H Lundbeck A/S (HLUNb.CO), opens new tab has agreed to buy U.S.-based Longboard Pharmaceuticals (LBPH.O), opens new tab for $2.6 billion, marking the biggest deal ever by the ...